Economic Times |
Cipla Ltd launches copy of GSK's top asthma drug in Germany, Sweden
Economic Times MUMBAI: Cipla Ltd has launched an anti-asthma inhaler in Germany and Sweden that is a generic version of GlaxoSmithKline Plc's Advair, a move that will further dent sales of the British firm's top-selling product. Cipla's drug will be marketed under … |
View full post on asthma – Google News